bioAffinity Techn…
USUSDbioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Liczba giełd, na których notowane są akcje spółki: 1. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.
O Firmie
- Strona
- bioaffinitytech.com
- Relacje Inwestorskie
- bioaffinitytech.com/contact/
- Sektor
- Health Care · Biotechnology: Commercial Physical & Biological Resarch
- Siedziba
- SAN ANTONIO, United States
- Prezes
- Maria Zannes
- Pracownicy
- 57
- Akcje w Obrocie
- 8.1 mln na 2026-08-03
- Free Float
- 532 257
- Kapitalizacja Rynkowa
- 3.69 mln USD
- Insiderzy
- 0.82%
- Inwestorzy Instytucjonalni
- 5.62%
- Branża (SIC)
- Services-Commercial Physical & Biological Research
- P/E
- strata
- FCF
- −11.6 mln USD
- Dług
- 36.5 tys. USDgotówka netto
- Zyski i FCF — za 12 miesięcy do 30.06.2026 roku (najnowszy raport firmy).
- NAV
Opis
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Giełdy i Tickery
| Giełda | Ticker | Waluta | Cena | Typ |
|---|---|---|---|---|
| US USA Stocks | BIAF | USD | 3.66 +4.27% | akcje zwykłe |
Wiadomości w Tym Tygodniu
Komunikaty prasowe ze strony firmy dla inwestorów, aktualizowane codziennie. Linki prowadzą na stronę firmy. Nagłówki są w oryginalnym języku, jak na stronie internetowej firmy.
Najwięksi Akcjonariusze
| Posiadacz | Udział | Akcje | Data Raportu |
|---|---|---|---|
| ZANNES MARIA (Chief Exec… | ≈46.94% | 280 359 | 2025-01-10 |
| EDWARDS JAMES MICHAEL CP… | ≈20.11% | 120 128 | 2025-01-10 |
| ZANNES TIMOTHY PETER (Ge… | ≈9.17% | 54 765 | 2025-01-10 |
| REVELES XAVIER TRINIDAD… | ≈7.02% | 41 943 | 2025-01-10 |
| Sabby Management, LLC | 4.06% | 24 377 | 2026-06-30 |
| Blackrock Inc. | 1.1% | 6 585 | 2026-06-30 |
| Vanguard Capital Managem… | 0.62% | 3 703 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.62% | 3 703 | 2026-06-30 |
| Geode Capital Management… | 0.57% | 3 398 | 2026-06-30 |
| J. Safra Sarasin Holding… | 0.47% | 2 840 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.34% | 2 071 | 2026-06-30 |
| Susquehanna Internationa… | 0.3% | 1 791 | 2026-06-30 |
| Jane Street Group, LLC | 0.3% | 1 786 | 2026-06-30 |
| Fidelity Concord Street… | 0.28% | 1 659 | 2026-07-31 |
| State Street Corporation | 0.27% | 1 606 | 2026-06-30 |
| HRT Financial LP | 0.23% | 1 389 | 2026-06-30 |
| Fidelity Concord Street… | 0.08% | 509 | 2026-07-31 |
| Fidelity Concord Street… | 0.07% | 434 | 2026-07-31 |
| Fidelity Concord Street… | 0.03% | 167 | 2026-07-31 |
| GIRGENTI STEVEN (Officer… | — | 1.09 mln | 2025-01-10 |
